Caloric vestibular stimulation can provide relief for migraine sufferers

The application of gentle cooling and warming currents inside the ear canal can provide relief for migraine sufferers, new research at the University of Kent has helped show.

Volunteers in the study who had a history of migraines experienced a significant reduction in the number of migraines they normally experienced in a month after using a technique known as caloric vestibular stimulation (CVS).

CVS activates the balance organs which are believed to alter activity in the area of the brain, known as the brainstem, associated with the onset of migraine headaches.

Dr. David Wilkinson, of the University's School of Psychology, helped lead the randomized, double-blinded, placebo-controlled trial. It was carried out across the US and UK, involving 81 volunteers with a history of between four and 14 migraine attacks per month.

The volunteers self-administered caloric vestibular stimulation daily for 20 minutes over a period of three months. The thermal currents were delivered by aluminium earpieces seated within padded headphones, powered and controlled by a small, hand-held device.

The findings demonstrated that the treatment reduced both the number of migraine days per month (the active treatment group experienced a reduction of 3.6 days compared to 0.9 days in the placebo group) as well as headache pain and the consequent need for migraine abortive prescription medications.

Dr. Wilkinson said the results indicated that vestibular stimulation 'may address the existing need for new preventative therapies for episodic migraine.

The findings were presented at the American Headache Society's annual meeting in June, where Professor Peter Goadsby, Chair of its Science Committee, said that 'many patients want non-drug options, so developing a non-drug therapy such as this may provide that.'

A second, expanded study will begin this summer, involving another collaboration between the University of Kent and US medical device company Scion Neurostim, who produced the CVS delivery device and will again fund the study, as well as local GP surgeries and specialist headache centers across the UK and US.

Comments

  1. Beth Barnes-Trellis Beth Barnes-Trellis United States says:

    I would like to try this unit out. I suffer from chronic migraines and can not function most days. I am not able to work, and help support my family.  How do I find out about bring a test subject?   BethT.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Epigenomic dynamics shape human brain development and neuropsychiatric disorder risks